A number of presentations at last week's San Antonio Breast Cancer Symposium focused on personalized approaches to treating breast cancer.
The following studies represent some of the highlights from SABCS.
Roche Presents Data on Pertuzumab in HER2-Positive Metastatic Breast Cancer
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.